185 related articles for article (PubMed ID: 8980350)
1. Differentiation of primary and secondary cutaneous B-cell lymphoma by Southern blot analysis.
Sepp N; Weyer K; Haun M; Zelger B; Thaler J; Faber V; Fritsch P; Grünewald K
Am J Clin Pathol; 1996 Dec; 106(6):749-57. PubMed ID: 8980350
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.
Kerl H; Fink-Puches R; Cerroni L
Keio J Med; 2001 Dec; 50(4):269-73. PubMed ID: 11806505
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L; Naghashpour M; Glass LF
Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous Lymphomas.
Joly P; Vasseur E; Esteve E; Leibowitch M; Tilly H; Vaillant L; Wechsler J; Thomine E; De Muret A; Dreyfus F
Br J Dermatol; 1995 Apr; 132(4):506-12. PubMed ID: 7748738
[TBL] [Abstract][Full Text] [Related]
6. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
Bergman R
Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
[TBL] [Abstract][Full Text] [Related]
7. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
8. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma.
Kulow BF; Cualing H; Steele P; VanHorn J; Breneman JC; Mutasim DF; Breneman DL
J Cutan Med Surg; 2002; 6(6):519-28. PubMed ID: 12404039
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features.
Kazakov DV; Burg G; Kempf W
Cesk Patol; 2002 Oct; 38(4):147-54. PubMed ID: 12629860
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous follicle center lymphoma -'crosti lymphoma': what can we learn?
Ziemer M; Bauer HI; Fluhr JW; Kaatz M; Elsner P
Am J Clin Dermatol; 2008; 9(2):133-6. PubMed ID: 18284269
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous B-Cell Lymphoma.
Goyal A; LeBlanc RE; Carter JB
Hematol Oncol Clin North Am; 2019 Feb; 33(1):149-161. PubMed ID: 30497672
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
Wilcox RA
Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous B-cell lymphoma].
Cortés B; Prins C
Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
[TBL] [Abstract][Full Text] [Related]
14. Gene rearrangement of bcl-1 and bcl-2 is confined to distinct subgroups of high-grade malignant B-cell lymphomas.
Ott MM; Dahlheimer K; Müller-Hermelink HK; Feller AC
J Pathol; 1993 Mar; 169(3):303-7. PubMed ID: 8492222
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
Lima M
An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
[TBL] [Abstract][Full Text] [Related]
16. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis.
Sangueza OP; Yadav S; White CR; Braziel RM
Am J Dermatopathol; 1992 Oct; 14(5):408-13. PubMed ID: 1415958
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
18. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
[TBL] [Abstract][Full Text] [Related]
19. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
[TBL] [Abstract][Full Text] [Related]
20. Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas.
Krenitsky A; Klager S; Hatch L; Sarriera-Lazaro C; Chen PL; Seminario-Vidal L
Am J Clin Dermatol; 2022 Sep; 23(5):689-706. PubMed ID: 35854102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
